The role of Intellectual Property Rights (IPR) is very effective in pharmaceutical and biotechnology industries. In pharmaceutical industry regarding health sector it clearly defines the market price of the drugs whereas during recession most company owners were spent their money to build the R&D and also they strengthened the IPR cells. It also clearly defines the patent, patent term restorati...

Martin S. Masar III (L), an associate with Katten Muchin Rosenman in Chicago, has a variety of experience in patent litigation and prosecution, as well as in other areas of intellectual property and antitrust litigation. His practice focuses on chemistry, pharmaceutical arts, nanotechnology and biotechnology. Thomas J. Maas (R), an associate with the firm, concentrates his practice on resolving...

Within the next 12 months there are intellectual property deadlines looming for developing countries that could have a significant impact on their future access to medicines. These relate to the World Trade Organisation’s (WTO) Trade Related Aspects of Intellectual Property Rights (TRIPS) Agreement. This Agreement outlines the intellectual property obligations for all 144 WTO members, including...

BACKGROUND The World Trade Organisation's Declaration on the TRIPS Agreement and Public Health (known as the Doha Declaration) of 2001, and subsequent Decision on the Interpretation of Paragraph 6 reached in 2003, affirmed the flexibilities available under the Agreement on Trade Related Property Rights (TRIPS) to member states seeking to protect public health. Despite these important clarificat...

BACKGROUND The reform of pharmaceutical policy can often involve trade-offs between competing social and commercial goals. Canada's Access to Medicines Regime (CAMR), a legislative amendment that permits compulsory licensing for the production and export of medicines to developing countries, aimed to reconcile these goals. Since it was passed in 2004, only two orders of antiretroviral drugs, en...

Pharmaceutical materials science being a fundamental branch that continuously provides important insights, theories, and technologies to formulation sciences. The recent advances in this area have brought the possibility to produce pharmaceutical materials by design. In particular, the formation of co-crystals, i.e. crystalline molecular complexes of twoor more neutral molecules, represents a p...